SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare trades jubilantly despite reporting 23% drop in Q1 consolidated net profit

04 Aug 2016 Evaluate

Cadila Healthcare is currently trading at Rs. 373.00, up by 26.00 points or 7.49% from its previous closing of Rs. 347.00 on the BSE.

The scrip opened at Rs. 349.80 and has touched a high and low of Rs. 374.70 and Rs. 349.80 respectively. So far 340305 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 454.40 on 23-Oct-2015 and a 52 week low of Rs. 295.50 on 18-Jan-2016.

Last one week high and low of the scrip stood at Rs. 374.70 and Rs. 342.00 respectively. The current market cap of the company is Rs. 37223.28 crore.

The promoters holding in the company stood at 74.79%, while institutions and non-institutions held 16.87% and 8.33% respectively.

Cadila Healthcare has reported 70.78% fall in its net profit at Rs 165.10 crore for the quarter ended June 30, 2016 as compared to Rs 565.00 crore for the same quarter in the previous year. The company’s total income decreased by 31.94% to Rs 1315.50 crore for the quarter under review from Rs 1932.90 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 22.60% fall in its net profit after taxes, minority interest and share of profit of associates and joint venture at Rs 356.20 crore for the quarter ended June 30, 2016 as compared to Rs 460.20 crore for the same quarter in the previous year. Total Income of the company decreased by 4.33% to Rs 2302.40 crore for the quarter under review from Rs 2406.60 crore for the same quarter ended June 30, 2015.

Zydus Lifesciences Share Price

942.55 3.35 (0.36%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×